M&A Deal Summary

Nobilis Health Acquires Hamilton Vein

On January 9, 2017, Nobilis Health acquired life science company Hamilton Vein for 13M USD

Acquisition Highlights
  • This is Nobilis Health’s 1st transaction in the Life Science sector.
  • This is Nobilis Health’s 2nd largest (disclosed) transaction.
  • This is Nobilis Health’s 5th transaction in the United States.
  • This is Nobilis Health’s 4th transaction in Texas.

M&A Deal Summary

Date 2017-01-09
Target Hamilton Vein
Sector Life Science
Buyer(s) Nobilis Health
Deal Type Add-on Acquisition
Deal Value 13M USD

Target

Hamilton Vein

Sugar Land, Texas, United States
Hamilton Vein, Inc. (Hamilton Vein Center) is a provider of clinical and surgical procedures for vascular disease.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Nobilis Health

Houston, Texas, United States

Category Company
Founded 2007
Sector Healthcare Services
Employees700
Revenue 300M USD (2017)
DESCRIPTION

Nobilis Health is a full-service healthcare development and management company which currently owns or manages four surgical hospitals and five ASCs, partners with thirty-three additional facilities throughout the country, and markets six independent brands. Nobilis Health was founded in 2007 and is based in Houston, Texas.


DEAL STATS #
Overall 5 of 5
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 4 of 4
State: Texas M&A 4 of 4
Country: United States M&A 5 of 5
Year: 2017 M&A 1 of 1
Size (of disclosed) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-08-01 Arizona Vein & Vascular Center

Surprise, Arizona, United States

Arizona Vein & Vascular Center and its four affiliated surgery centers operating as The Arizona Center for Minimally Invasive Surgery are a clinical and surgical providers for vascular, radiology, podiatry, and general surgery, with five locations in the Phoenix and Tucson metropolitan areas.

Buy $22M